Enzyme replacement therapy

Results: 54



#Item
41Microsoft PowerPoint - Fabry Figures Alison FINAL 2.ppt [Compatibility Mode]

Microsoft PowerPoint - Fabry Figures Alison FINAL 2.ppt [Compatibility Mode]

Add to Reading List

Source URL: www.fabry.org

Language: English - Date: 2014-10-06 22:04:03
42Microsoft PowerPoint - Fabry Registry annual report figures redrawn Alison FINAL 2012 revised 2.ppt [Compatibility Mode]

Microsoft PowerPoint - Fabry Registry annual report figures redrawn Alison FINAL 2012 revised 2.ppt [Compatibility Mode]

Add to Reading List

Source URL: www.fabry.org

Language: English - Date: 2014-10-06 18:39:38
43Minimum Recommended Schedule of Assessments for Monitoring Patients with Fabry Disease All Patients Upon Enrollment  Dr. A. Fouilhoux l Lyon, France

Minimum Recommended Schedule of Assessments for Monitoring Patients with Fabry Disease All Patients Upon Enrollment Dr. A. Fouilhoux l Lyon, France

Add to Reading List

Source URL: www.fabry.org

Language: English - Date: 2014-10-06 21:28:23
44Dear Nominator(s): (insert name of nominators[s])

Dear Nominator(s): (insert name of nominators[s])

Add to Reading List

Source URL: www.hrsa.gov

Language: English - Date: 2012-01-07 00:53:45
45APPROVAL OF REPLAGAL™ WITH CONDITIONS Conditional marketing approval has been granted for Replagal™ for the following indications: Replagal shows promising preliminary evidence of efficacy for the treatment of patien

APPROVAL OF REPLAGAL™ WITH CONDITIONS Conditional marketing approval has been granted for Replagal™ for the following indications: Replagal shows promising preliminary evidence of efficacy for the treatment of patien

Add to Reading List

Source URL: www.hc-sc.gc.ca

Language: English - Date: 2013-07-12 14:26:09
46Conditional Approval of Replagal™ (agalsidase alfa) Fact Sheet What is Replagal™ (agalsidase alfa)?

Conditional Approval of Replagal™ (agalsidase alfa) Fact Sheet What is Replagal™ (agalsidase alfa)?

Add to Reading List

Source URL: www.hc-sc.gc.ca

Language: English - Date: 2013-07-12 14:26:09
47CFA Members GenzymeShortage

CFA Members GenzymeShortage

Add to Reading List

Source URL: www.fabrycanada.com

Language: English - Date: 2012-02-26 16:46:11
48Nova Scotians urged to participate in study of Fabry Disease Health facts Q&A on Fabry disease Q: What is Fabry disease? A: Fabry disease is an inherited,

Nova Scotians urged to participate in study of Fabry Disease Health facts Q&A on Fabry disease Q: What is Fabry disease? A: Fabry disease is an inherited,

Add to Reading List

Source URL: www.fabrycanada.com

Language: English - Date: 2012-02-26 16:46:12
49Amicus Therapeutics Announces FDA Agreement to Commence Phase 2 Study of AT2220 Co-administered with Enzyme Replacement Therapy for Pompe Disease CRANBURY, N.J., March 8, 2011 /PRNewswire/ -- Amicus Therapeutics (Nasdaq:

Amicus Therapeutics Announces FDA Agreement to Commence Phase 2 Study of AT2220 Co-administered with Enzyme Replacement Therapy for Pompe Disease CRANBURY, N.J., March 8, 2011 /PRNewswire/ -- Amicus Therapeutics (Nasdaq:

Add to Reading List

Source URL: www.unitedpompe.com

Language: English - Date: 2011-03-08 17:31:25
50Amicus Therapeutics Announces Second Quarter 2007 Financial Results

Amicus Therapeutics Announces Second Quarter 2007 Financial Results

Add to Reading List

Source URL: www.unitedpompe.com

Language: English - Date: 2011-12-11 11:39:13